The best indicator for Cognizant (CTSH)
We backtested 20 indicators across daily, weekly and hourly charts on real Cognizant (CTSH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the weekly chart, this is the strongest risk-adjusted edge we found for Cognizant (CTSH) over ~28.1 years — trailing buy-and-hold by 12.8% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) | Daily | 13.6% | 0.56 | -49.9% | 70.4% | 98 | -8.9% |
| 2 | Stochastic | Daily | 11.1% | 0.51 | -59.2% | 72.7% | 139 | -11.4% |
| 3 | ADX / DMI | Weekly | 10.1% | 0.48 | -63.0% | 51.1% | 45 | -12.3% |
| 4 | Money Flow Index | Daily | 9.4% | 0.45 | -60.1% | 80.0% | 25 | -13.1% |
| 5 | EMA 20/50 Cross | Weekly | 10.6% | 0.45 | -82.3% | 37.5% | 16 | -11.8% |
| 6 | WaveTrend (8/6/4) ✓ | Weekly | 9.6% | 0.45 | -39.7% | 63.6% | 22 | -12.8% |
| 7 | RSI Trend (>50) | Weekly | 9.9% | 0.44 | -70.6% | 42.7% | 89 | -12.5% |
| 8 | Donchian Breakout | Weekly | 8.7% | 0.44 | -68.6% | 55.0% | 20 | -13.7% |
| 9 | Donchian Midline | Weekly | 9.8% | 0.44 | -72.7% | 44.2% | 77 | -12.6% |
| 10 | Williams %R | Daily | 8.3% | 0.42 | -55.2% | 72.2% | 187 | -14.2% |
| 11 | Bollinger Breakout | Weekly | 8.3% | 0.42 | -57.9% | 46.7% | 30 | -14.1% |
| 12 | Rate of Change | Weekly | 8.9% | 0.42 | -76.6% | 45.8% | 83 | -13.5% |
| 13 | RSI Trend (>50) ✓ | Daily | 8.3% | 0.41 | -70.9% | 40.3% | 395 | -14.3% |
| 14 | CCI ✓ | Weekly | 7.5% | 0.41 | -49.5% | 74.1% | 27 | -14.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Cognizant (CTSH), WaveTrend (8/6/4) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.